Biotech

All Articles

Otsuka pays out $800M for Jnana and its clinical-stage PKU drug

.Otsuka Drug has gotten Boston-based Jnana Therapies for $800 million so the Eastern biotech can get...

FibroGen gives up 75% people personnel as possession fails 2 more tests

.FibroGen is significantly restructuring its company, laying off 75% of its USA workers as well as q...

Tracon relax full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has made a decision to relax functions full weeks after an injectable immune...

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on stopped working epilepsy medication, proclaims FDA manage

.We actually understand that Takeda is wishing to find a road to the FDA for epilepsy medication sot...

VBI Injections declare insolvency, finds possession purchase

.Immunology biotech VBI Vaccines is actually drifting precariously close to the point of no return, ...

Celldex anti-cKIT antibody lessen colonies in another period 2 research

.It is actually not easy to muscle in on an area as competitive as immunology, yet Celldex Rehabs be...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical invuln...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's health condition medication did not assist people attain remission in a...

Cognition's stage 2 radiate information tarnish Alzheimer's possibility

.Cognition Therapeutics' period 2 SHINE trial has actually taken some of the gloss off the Alzheimer...